Key facts
- This page summarizes Daniel Patrick McGuire's Form 4 filing for Vanda Pharmaceuticals Inc. (VNDA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jun 2026, 16:39.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Represents shares of common stock underlying an RSU award. The RSU vests in four (4) equal annual installments with the first annual vest taking place on June 4, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.